Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients

Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device... OBES SURG (2017) 27:3306–3313 DOI 10.1007/s11695-017-2939-4 NEW CONCEPT Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients 1 2,3 1 2,3 Patrice M. Forner & Timothy Ramacciotti & John E. Farey & Reginald V. Lord Published online: 11 October 2017 Springer Science+Business Media, LLC 2017 Abstract acute pancreatitis. Seventy-four percent of patients experi- Background The duodenal-jejunal bypass liner (DJBL) is an enced weight gain after removal with a mean 4.5 ± 6.1 kg endoscopically placed device designed to achieve weight loss (p < 0.0001) within the first 6 months after explantation. and improve glycemic control in obese patients. Previous Conclusions The DJBL provides significant but highly vari- studies report promising results but typically included small able weight loss. Glycemic control was variable. Most insulin- patient numbers and short follow-up. This study aims to de- requiring T2DM patients ceased or reduced insulin. Most pa- termine the safety and effectiveness of the device. tients experience an adverse event and most regain significant Methods Study design: weight after device removal. Major adverse events can occur, A series of all patients treated by the DJBL at our including the potentially life-threatening complications of he- institutions. patic abscess http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Obesity Surgery Springer Journals

Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients

Loading next page...
 
/lp/springer_journal/safety-and-effectiveness-of-an-endoscopically-placed-duodenal-jejunal-Vf00sLugtp
Publisher
Springer US
Copyright
Copyright © 2017 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Surgery
ISSN
0960-8923
eISSN
1708-0428
D.O.I.
10.1007/s11695-017-2939-4
Publisher site
See Article on Publisher Site

Abstract

OBES SURG (2017) 27:3306–3313 DOI 10.1007/s11695-017-2939-4 NEW CONCEPT Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients 1 2,3 1 2,3 Patrice M. Forner & Timothy Ramacciotti & John E. Farey & Reginald V. Lord Published online: 11 October 2017 Springer Science+Business Media, LLC 2017 Abstract acute pancreatitis. Seventy-four percent of patients experi- Background The duodenal-jejunal bypass liner (DJBL) is an enced weight gain after removal with a mean 4.5 ± 6.1 kg endoscopically placed device designed to achieve weight loss (p < 0.0001) within the first 6 months after explantation. and improve glycemic control in obese patients. Previous Conclusions The DJBL provides significant but highly vari- studies report promising results but typically included small able weight loss. Glycemic control was variable. Most insulin- patient numbers and short follow-up. This study aims to de- requiring T2DM patients ceased or reduced insulin. Most pa- termine the safety and effectiveness of the device. tients experience an adverse event and most regain significant Methods Study design: weight after device removal. Major adverse events can occur, A series of all patients treated by the DJBL at our including the potentially life-threatening complications of he- institutions. patic abscess

Journal

Obesity SurgerySpringer Journals

Published: Oct 11, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off